Natreon Receives Strategic Investment From DSM
Natreon, Inc. (New Brunswick, NJ) has received an equity investment from DSM Venturing B.V., the corporate venture capital arm of the global life sciences and materials sciences company, Royal DSM (Heerlen, The Netherlands).
“We are pleased to welcome DSM as a strategic investor as we expand Natreon’s clinically proven, high-quality ayurvedic product lines,” said Natreon’s CEO and chairman, Dr. Sanni Raju. “DSM is a global leader in the dietary supplement market and their expertise and domain knowledge will help accelerate our growth. ”
“Natreon’s focus on rigorous science and clinically demonstrated natural herbal supplements separates them from their peers,” added Greg McParland, senior investment manager of DSM Venturing. “Their products are focused on highly relevant health and wellness categories that consumers are demanding. We are looking forward to supporting the Natreon team as they expand their business.”
For more information, visit www.natreoninc.com or www.dsm.com.
